Weekly Clinical Updates

As infectious diseases such as SARS, Monkeypox, Polio, HIV, and Ebola travel the globe and garner media attention, Parasites Without Borders staff are curating resources in a timely, ongoing basis. We believe the information posted here is worthy of further examination by the science and medical communities. Our primary goal remains to bring the latest medical and biological information to the forefront for researchers and practicing physicians.

Image of people on a boat getting across large body of water in tropical area

Throughout February, March And April, All Donations Made To Parasites Without Borders Will Be Matched By PWB And Donated To Floating Doctors

MicrobeTV Podcast

MicrobeTV is an independent podcast network for people who are interested in the life sciences. Our shows are about viruses, bacteria, parasites, evolution, immunology, and neuroscience.

Young woman receiving a vaccine injection in her arm

November 27, 2024

Association between Use of a Voluntary Isolation Centre and Reduced Household SARS-CoV-2 Transmission | Risks of SARS-CoV-2 JN.1 Infection and COVID-19–Associated Emergency Department Visits | Real Clinical Effectiveness of Molnupiravir against 30-day Mortality | Time to Sustained Recovery Among Outpatients With COVID-19 | Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 | Remdesivir for 5 or 10 Days in Patients | Remdesivir for Treatment of COVID-19 | Neurologic Manifestations of Long COVID Disproportionately Affect Young and Middle-age Adults
Nurse giving COVID-19 vaccine injection to a patient

November 21, 2024

Serological Evidence of Mpox Virus Infection During Peak Mpox Transmission in New York City, July to August 2022 | N95 Filtering Facepiece Respirator Reuse, Extended Use, and Filtration Efficiency | Enhanced Placental Antibody Transfer Efficiency with Longer Interval Between Maternal RSV Vaccination and Birth
Young Girl Receives COVID-19 Treatment

November 13, 2024

Real-world Effectiveness of Nirmatrelvir-Ritonavir and Molnupiravir in Non-hospitalised Adults with Covid-19: A Population-based, Retrospective Cohort Study (sic) Cohort Study | Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-Risk Patients Treated with Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized Trial | Post-acute Sequelae of SARS-CoV-2 Cardiovascular Symptoms are Associated with Trace-level Cytokines that Affect Cardiomyocyte Function

November 7, 2024

Symptoms Six Weeks After COVID-19 are Reduced Among US Health Care Personnel Receiving Additional Vaccine Doses During the Omicron Period, December 2021–April 2022 | Microbial Dynamics and Pulmonary Immune Responses in COVID-19 Secondary Bacterial Pneumonia | Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19
Women Taking a Step Towards Health

October 31, 2024

Repeated COVID-19 mRNA-based Vaccination Contributes to SARS-CoV-2 Neutralizing Antibody Responses in the Mucosa | SARS-CoV-2 XBB.1.5 mRNA Booster Vaccination Elicits Limited Mucosal Immunity | Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021–2022 | Nirmatrelvir Plus Ritonavir Reduces COVID-19 Hospitalization and Prevents Long COVID in Adult Outpatients | Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo - The ACTIV-6 Randomized Clinical Trial | Clinical and Functional Assessment of SARS-CoV-2 Sequelae among Young Marines – A Panel Study

October 24, 2024

The Risk of SARS-CoV-2 Transmission in Community Indoor Settings | Relative Effectiveness of the NVX-CoV2373 Vaccine Compared With the BNT162b2 Vaccine in Adolescents | Viral and Symptom Rebound Following Anti-SARS-CoV-2 Monoclonal Antibody Therapy in a Randomized Placebo-controlled Trial | The Importance of Including Long COVID Outcomes When Developing Novel Treatments for Acute COVID-19 | The Persistence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) after SARS-CoV-2 Infection

Situation Dashboards

World_Health_Organization_logo_logotype

World Health Organization (WHO)

Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
university-logo-small-horizontal-blue-no-clear-space-51c7fb4524

Johns Hopkins University (JHU)

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
1point3acres

COVID-19 in US and Canada

1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
image

Genomic Epidemiology COVID-19

Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.

Sources for COVID-19 Information

World_Health_Organization_logo_logotype

World Health Organization (WHO)

1280px-US_CDC_logo.svg

Centers for Disease Control, US

ProMED-Logo

International Society for Infectious Diseases

twiv-logo

This Week in Virology (TWIV)

[ctct form="259547" show_title="false"]

Parasites Without Borders

A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.

Donate to Parasites Without Borders Today!

Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.

Scroll to Top